Home Tags CD45-ADC

Tag: CD45-ADC

Early Clinical Observations from MGTA-117 in Clinical Trial

ADC Review | Editorial Team
Hematopoietic stem-cell transplantation, also known as a bone marrow transplant, includes the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral...

Preclinical Data from Magenta’s CD45-ADC Demonstrates Successful Immune Reset to Halt...

ADC Review | Editorial Team
Data presented during the 46th annual (virtual) meeting of the European Society for Blood and Marrow Transplantation (EBMT), held August 29 to September 1,...

How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic Payloads...

Jon Gingrich
Antibody-drug Conjugates or ADCs combine the selectivity of antibodies with the efficacy of small molecule drugs, allowing for more precise, targeted, therapeutic applications. Combining the...
General Views during at the American College of Rheumatology Annual Meeting, held November 8 - 13, 2019 in Atlanta, Georgia. Photo courtesy 2019 © ACR.

First Immune Reset with Single dose of CD45-ADC in Multiple Autoimmune...

ADC Review | Editorial Team
Data showing successful immune reset with a single dose of CD45-ADC, an antibody-drug conjugate, in models of three autoimmune diseases, were presented at the...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X